Skip to contentY
Yubo International Biotech Ltd
Y
YBGJYubo International Biotech Ltd Q2 2026 · 10-Q
Revenue$0.00$0.00— vs Q2 2025 Net Income-$247.95K-$247.95KN/M vs Q2 2025 EPS Diluted$0.00$0.00— vs Q2 2025 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Yubo International Biotech Ltd · CIK 895464 · Engraved from SEC EDGAR
-$238,860
N/M
Operating Cash Flowderived-$84,104N/M ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end